driving toward net-zero

13 initiatives receive grant funding from new EV-focused, Houston-led program

Mayor Sylvester Turner announced the grant recipients last week. Photo via evolvehouston.org

Evolve Houston awarded its inaugural microgrants this week to 13 groups, neighborhoods and an individual working to make electric vehicles accessible to all Houstonians.

Launched in 2022, Evolve's eMobility Microgrant Initiative supports community efforts that propose electric vehicle, micro-mobility and charging infrastructure projects in some of Houston's most underserved neighborhoods. The grants ranged from $10,000 to $15,000.

Shell, NRG, CenterPoint, the University of Houston, and the city of Houston are partners in Evolve Houston. GM and bp America helped found the microgrant program.

“The eMobility Microgrant Initiative is a culmination of my vision and the collaborative efforts from many individuals and corporate supporters who recognize the importance of the transition to electric transportation,” Houston Mayor Sylvester Turner says in a statement. “The grant winners we recognized today are trailblazers in their communities, leveraging EV technology to residents in neighborhoods that have been historically underserved.”

Winners of the Round 1 eMobility Microgrants and their proposed projects included:

  • Alliance for Multicultural Community Services: Adding a charging station for the Gulfton area and a youth advocacy initiative
  • Third Ward Real Estate Council & Northern Third Ward Neighborhood Implementation Project: Introducing an interactive “mobility hub” to show what EV infrastructure would look like in Third Ward
  • Coalition of Community Organizations: Bringing eBikes and a charging station in the Fifth Ward
  • Edison Arts Foundation: Installing an EV charging station and green energy awareness at the Edison Center in Fort Bend
  • GROW: Promoting green energy careers to youth in underserved communities through EV education and outreach events
  • Hiram Clarke Fort Bend Houston Redevelopment Authority: Brining a bike share program to Southwest Houston
  • Houston Southeast: Expanding its existing rideshare program that offers free and reduced rides in partnership with Uber EV fleet of electric vehicles
  • Pangea Charging: Adding EV chargers to two Complete Communities apartment complexes/buildings
  • RYDE: Brining a free micro-transit service in the Third Ward, including two electric shuttles that could serve more than 1,000 passengers per month
  • Shawn R. Owens: Introducing a new eBike food delivery service, called Electric Eats, to bring food from from the Third Ward food pantries to the area's senior, underserved and immobile residents
  • South Union Community Development Corporation: Creating a workforce development program for green energy careers
  • The Reflections of Christ's Kingdom (The R.O.C.K.) Church–BroadwayCampus: Adding a DC-Fast charger in the South Houston/Hobby Airport area
  • University of Houston-Downtown: Installing a no-cost EV charging station on campus

“This program is designed to provide launch funding to community-based, EV ecosystem-related projects," says Evolve Houston President and Executive Director Casey Brown. "We see significant opportunities to make meaningful progress by using an exciting new technology that is centered around community-based direction. Our governance system puts the community in charge and knows that the ideas of those that know their communities best will carry the greatest impact.”

Applications for the second round of microgrants are now open.Information can be found here. The application deadline is Friday, September 22, 2023.

Evolve Houston was founded in 2019 through Houston's Climate Action Plan. The nonprofit relaunched in 2022, naming Brown as its new president and executive director. The organization's main goal is to improve air quality, reduce greenhouse gas and to accelerate EV adoption so that half of all new vehicles sold in the Houston area would be EVs by 2030.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted